Larkin Finbar 4
4 · Jazz Pharmaceuticals plc · Filed Mar 10, 2021
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Operations
Transactions
- Sale
Ordinary Shares
[F1][F2]2021-03-08$161.60/sh−1,509$243,859→ 16,519 total
Footnotes (2)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $161.5994 to $161.6046. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Signature
By: /s/Adam Guttmann, as attorney in fact For: Finbar Larkin|2021-03-10